Bianca F. Goemans
Pediatric Oncology and Hematology
VU University Medical Center
Amsterdam
Netherlands
Name/email consistency: high
- FLT3 and KIT mutated pediatric acute myeloid leukemia (AML) samples are sensitive in vitro to the tyrosine kinase inhibitor SU11657. Goemans, B.F., Zwaan, C.M., Cloos, J., de Lange, D., Loonen, A.H., Reinhardt, D., Hählen, K., Gibson, B.E., Creutzig, U., Kaspers, G.J. Leuk. Res. (2010)
- Mutations in KIT and RAS are frequent events in pediatric core-binding factor acute myeloid leukemia. Goemans, B.F., Zwaan, C.M., Miller, M., Zimmermann, M., Harlow, A., Meshinchi, S., Loonen, A.H., Hählen, K., Reinhardt, D., Creutzig, U., Kaspers, G.J., Heinrich, M.C. Leukemia (2005)
- In vitro profiling of the sensitivity of pediatric leukemia cells to tipifarnib: identification of T-cell ALL and FAB M5 AML as the most sensitive subsets. Goemans, B.F., Zwaan, C.M., Harlow, A., Loonen, A.H., Gibson, B.E., Hählen, K., Reinhardt, D., Creutzig, U., Heinrich, M.C., Kaspers, G.J. Blood (2005)